Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Innoviva (INVA) over the last 16 years, with Q2 2024 value amounting to $17.1 million.

  • Innoviva's Other Accumulated Expenses fell 2386.01% to $17.1 million in Q2 2024 from the same period last year, while for Jun 2024 it was $17.1 million, marking a year-over-year decrease of 2386.01%. This contributed to the annual value of $19.7 million for FY2023, which is 711.56% down from last year.
  • Per Innoviva's latest filing, its Other Accumulated Expenses stood at $17.1 million for Q2 2024, which was down 2386.01% from $23.7 million recorded in Q1 2024.
  • Innoviva's Other Accumulated Expenses' 5-year high stood at $24.9 million during Q1 2023, with a 5-year trough of $734000.0 in Q1 2020.
  • Over the past 5 years, Innoviva's median Other Accumulated Expenses value was $11.6 million (recorded in 2022), while the average stood at $11.3 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first crashed by 4401.15% in 2020, then surged by 204300.0% in 2022.
  • Quarter analysis of 5 years shows Innoviva's Other Accumulated Expenses stood at $1.4 million in 2020, then dropped by 28.03% to $1.0 million in 2021, then soared by 2001.78% to $21.2 million in 2022, then fell by 7.12% to $19.7 million in 2023, then dropped by 13.02% to $17.1 million in 2024.
  • Its Other Accumulated Expenses stands at $17.1 million for Q2 2024, versus $23.7 million for Q1 2024 and $19.7 million for Q4 2023.